Durable Complete Response achieved in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL) patient treated with a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy with a PD-1 Knockout: Case Report from the CB-010 ANTLER Trial

Brem Elizabeth,Pinter-Brown Lauren, Kirk Christina, Matsuda Emiri,Johnson Blake,Hammad Ashley, Mastey Donna, Chung Shally, Bird Kalin, Thompson Ben, Ledergor Guy,Davi Franco, Garrett Ashraf,Garner Elizabeth, Zudaire Enrique,Kanner Steven,Nesheiwat Tonia,Portella Socorro,Rizvi Syed, O'Brien Susan

AMERICAN JOURNAL OF HEMATOLOGY(2023)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要